Consensus Afya Limited

Stocks

AFYA

KYG011251066

School, College & University

Delayed Nasdaq 23:00:00 18/09/2026 +03			5-day change	1st Jan Change
13.60 ^USD	-0.29%		-2.09%	-11.75%

09-18	Afya Gains Approval for 17 Additional Medical Seats in Brazil	MT
08-24	LatAm markets mixed as investors assess U.S. sanctions on Iran, Mexico data	RE

Evolution of the Average Target: Afya Limited

Evolution of the Target Price: Afya Limited

Changes in Analyst Recommendations: Afya Limited

30772c1d9e37fc37bb143aad948.2p8wiy5QToTxxFOyWjl5aYDmPTAB-i0DmPGddTFiteY.rvNl-X0ldsGwtBzzH30bHfmlUERIjXhA3sbwIH9S4bmcpwW6SzwI0Z-HZw~293ae0a75346b112a11aff4216b87bf4

Analysts' recommendations: Afya Limited

02-24	BofA Securities Downgrades Afya to Neutral From Buy, Price Target is $17	MT
02-13	Afya Shares Fall After Morgan Stanley Downgrade	MT
02-13	Morgan Stanley Downgrades Afya to Underweight From Equalweight, Adjusts Price Target to $16 From $17.50	MT
01-16	UBS Downgrades Afya to Neutral From Buy, Adjusts PT to $16 From $18	MT
01-08	UBS Trims Afya Price Target to $18 From $19, Maintains Buy Rating	MT
01-07	JPMorgan Downgrades Afya to Neutral From Overweight, Adjusts Price Target to $22 From $24.50	MT
08/09/25	UBS Upgrades Afya to Buy From Neutral, $19 Price Target	MT
08/09/25	JPMorgan Upgrades Afya to Overweight, Price Target is $24.50	MT
06/08/25	Afya Shares Rise After Morgan Stanley Upgrade	MT
06/08/25	Morgan Stanley Upgrades Afya to Equalweight From Underweight, Adjusts Price Target to $17.50 From $19	MT
29/07/25	Citigroup Upgrades Afya to Neutral From Sell, Adjusts Price Target to $14 From $16	MT
12/06/25	UBS Hikes Afya Price Target to $19.50 From $17.50, Maintains Neutral Rating	MT
11/03/25	Morgan Stanley Downgrades Afya to Underweight From Equal Weight, Cuts Price Target to $17 From $19	MT
05/02/25	Bradesco BBI Downgrades Afya to Underperform From Neutral, Adjusts Price Target to $14 From $17	MT
31/01/25	Citigroup Downgrades Afya to Sell From Neutral, Adjusts Price Target to $15 From $18	MT
17/12/24	UBS Cuts Price Target on Afya to $17.50 From $19.50, Keeps Neutral Rating	MT
30/08/24	UBS Initiates Coverage on Afya With Neutral Rating, Sets $19.50 Price Target	MT
21/06/24	Morgan Stanley Adjusts Price Target on Afya to $19 From $21, Maintains Equalweight Rating	MT
27/11/23	JPMorgan Downgrades Afya to Neutral From Overweight, Adjusts Price Target to $23 From $22	MT
22/11/22	Credit Suisse Adjusts Afya's Price Target to $18 From $19, Keeps Outperform Rating	MT
13/10/22	UBS Adjusts Afya Price Target to $18 From $21, Maintains Buy Rating	MT
08/04/22	Credit Suisse Upgrades Afya to Outperform from Neutral, Adjusts Price Target to $19 from $18	MT
07/03/22	UBS Adjusts Afya Price Target to $21 From $27, Maintains Buy Rating	MT
15/02/22	Goldman Sachs Adjusts Afya's Price Target to $19 From $29, Reiterates Buy Rating	MT
21/07/21	Afya : Morgan Stanley Downgrades Afya to Equalweight from Overweight, Adjusts Price Target to $28.50 from $32	MT

More recommendations

School, College & University (NEC)

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
AFYA LIMITED			+24.63%
GRAHAM HOLDINGS COMPANY	-	-	-13.42%
PHOENIX EDUCATION PARTNERS, INC.			+55.31%
COGNA EDUCAÇÃO S.A.			+62.7%
CHINA EDUCATION GROUP HOLDINGS LIMITED			+63.61%
YDUQS PARTICIPAÇÕES S.A.			+49.67%
CAIRO FOR INVESTMENT AND REAL ESTATE DEVELOPMENTS-CIRA EDUCATION	-	-	-
VITRU EDUCAÇÃO S.A.			+32.32%
CRUZEIRO DO SUL EDUCACIONAL S.A.			+25.99%
Average			+37.60%
Weighted average by Cap.			+16.65%